Cargando…

Does COVID-19 vaccine exacerbate rotator cuff symptoms? A prospective study

BACKGROUND: Shoulder injury related to vaccine administration (SIRVA) is a rare but increasing complication after vaccination. The aim of this study was to increase awareness of post-vaccination shoulder pain and to investigate the effect of the clinical condition of the shoulder before vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: İğrek, Servet, Ulusoy, İbrahim, Çeliksöz, Aytek Hüseyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318763/
https://www.ncbi.nlm.nih.gov/pubmed/37403025
http://dx.doi.org/10.1186/s12891-023-06660-y
_version_ 1785068109022887936
author İğrek, Servet
Ulusoy, İbrahim
Çeliksöz, Aytek Hüseyin
author_facet İğrek, Servet
Ulusoy, İbrahim
Çeliksöz, Aytek Hüseyin
author_sort İğrek, Servet
collection PubMed
description BACKGROUND: Shoulder injury related to vaccine administration (SIRVA) is a rare but increasing complication after vaccination. The aim of this study was to increase awareness of post-vaccination shoulder pain and to investigate the effect of the clinical condition of the shoulder before vaccination on the loss of function that may occur after vaccination. METHODS: This prospective study included 65 patients aged > 18 years who were diagnosed with unilateral shoulder impingement and/or bursitis. The first vaccination was performed on the shoulders with rotator cuff symptoms, then the second vaccination was performed on healthy shoulders of same patients as soon as the health system allowed. Pre-vaccination MRI of the symptomatic shoulders of the patients was performed and VAS, ASES and Constant scores were evaluated. At 2 weeks after vaccination of the symptomatic shoulder, scores were reassessed. For the patients with changes in the scores, MRI was performed again and the treatment of all patients was started. A second vaccination was given to asymptomatic shoulders and the patients were recalled two weeks later and their scores were evaluated. RESULTS: After vaccination, the symptomatic shoulder of 14 patients was affected. No clinical changes were observed in the asymptomatic shoulders after vaccination. The VAS scores of the symptomatic shoulders evaluated after vaccination were significantly higher than the scores evaluated before vaccination (p = 0.001). The ASES and Constant scores of symptomatic shoulders evaluated after vaccination were significantly decreased compared to the scores evaluated before vaccination (p = 0.001). CONCLUSIONS: Exacerbation of symptoms may occur if symptomatic shoulders are vaccinated. Before vaccination, a detailed anamnesis should be taken from the patients and vaccination should be performed to the asymptomatic side.
format Online
Article
Text
id pubmed-10318763
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103187632023-07-05 Does COVID-19 vaccine exacerbate rotator cuff symptoms? A prospective study İğrek, Servet Ulusoy, İbrahim Çeliksöz, Aytek Hüseyin BMC Musculoskelet Disord Research BACKGROUND: Shoulder injury related to vaccine administration (SIRVA) is a rare but increasing complication after vaccination. The aim of this study was to increase awareness of post-vaccination shoulder pain and to investigate the effect of the clinical condition of the shoulder before vaccination on the loss of function that may occur after vaccination. METHODS: This prospective study included 65 patients aged > 18 years who were diagnosed with unilateral shoulder impingement and/or bursitis. The first vaccination was performed on the shoulders with rotator cuff symptoms, then the second vaccination was performed on healthy shoulders of same patients as soon as the health system allowed. Pre-vaccination MRI of the symptomatic shoulders of the patients was performed and VAS, ASES and Constant scores were evaluated. At 2 weeks after vaccination of the symptomatic shoulder, scores were reassessed. For the patients with changes in the scores, MRI was performed again and the treatment of all patients was started. A second vaccination was given to asymptomatic shoulders and the patients were recalled two weeks later and their scores were evaluated. RESULTS: After vaccination, the symptomatic shoulder of 14 patients was affected. No clinical changes were observed in the asymptomatic shoulders after vaccination. The VAS scores of the symptomatic shoulders evaluated after vaccination were significantly higher than the scores evaluated before vaccination (p = 0.001). The ASES and Constant scores of symptomatic shoulders evaluated after vaccination were significantly decreased compared to the scores evaluated before vaccination (p = 0.001). CONCLUSIONS: Exacerbation of symptoms may occur if symptomatic shoulders are vaccinated. Before vaccination, a detailed anamnesis should be taken from the patients and vaccination should be performed to the asymptomatic side. BioMed Central 2023-07-04 /pmc/articles/PMC10318763/ /pubmed/37403025 http://dx.doi.org/10.1186/s12891-023-06660-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
İğrek, Servet
Ulusoy, İbrahim
Çeliksöz, Aytek Hüseyin
Does COVID-19 vaccine exacerbate rotator cuff symptoms? A prospective study
title Does COVID-19 vaccine exacerbate rotator cuff symptoms? A prospective study
title_full Does COVID-19 vaccine exacerbate rotator cuff symptoms? A prospective study
title_fullStr Does COVID-19 vaccine exacerbate rotator cuff symptoms? A prospective study
title_full_unstemmed Does COVID-19 vaccine exacerbate rotator cuff symptoms? A prospective study
title_short Does COVID-19 vaccine exacerbate rotator cuff symptoms? A prospective study
title_sort does covid-19 vaccine exacerbate rotator cuff symptoms? a prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318763/
https://www.ncbi.nlm.nih.gov/pubmed/37403025
http://dx.doi.org/10.1186/s12891-023-06660-y
work_keys_str_mv AT igrekservet doescovid19vaccineexacerbaterotatorcuffsymptomsaprospectivestudy
AT ulusoyibrahim doescovid19vaccineexacerbaterotatorcuffsymptomsaprospectivestudy
AT celiksozaytekhuseyin doescovid19vaccineexacerbaterotatorcuffsymptomsaprospectivestudy